deltatrials
Completed NA INTERVENTIONAL 1-arm NCT01389232

The SeriScaffold® Use in Reconstruction Post Market Study for Tissue Support and Repair in Breast Reconstruction Surgery in Europe

Sponsor: Sofregen Medical, Inc.

Updated 8 times since 2017 Last updated: May 25, 2021 Started: Jun 30, 2011 Primary completion: Aug 31, 2013 Completion: Feb 28, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Soft Tissue Support and Repair, this trial is completed. The trial is conducted by Sofregen Medical, Inc. and has accumulated 8 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshotCompleted~Sep 2021 – ~Jul 2024 · 34 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

8 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Sep 2021 — Jul 2024 [monthly]

    Completed NA

  5. Jan 2021 — Sep 2021 [monthly]

    Completed NA

Show 3 earlier versions
  1. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  2. Feb 2017 — Jun 2018 [monthly]

    Completed NA

  3. Jan 2017 — Feb 2017 [monthly]

    Completed NA

    First recorded

Jun 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Sofregen Medical, Inc.
Data source: Sofregen Medical, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .